Results 281 to 290 of about 1,972,453 (318)
Some of the next articles are maybe not open access.
Medical Hypotheses, 1980
Survival times of treated cancer patients are distributed lognormally. This density function exhibits a peak accompanied by a long tail which asymptotically approaches the abscissa. The lognormal conditional failure rate, known also as force of mortality, which describes the chances of a patient remaining alive, initially climbs, to decline at a later ...
openaire +2 more sources
Survival times of treated cancer patients are distributed lognormally. This density function exhibits a peak accompanied by a long tail which asymptotically approaches the abscissa. The lognormal conditional failure rate, known also as force of mortality, which describes the chances of a patient remaining alive, initially climbs, to decline at a later ...
openaire +2 more sources
European Journal of Cancer and Clinical Oncology, 1990
INTRODUCTION RAPID advances in recombinant DNA technology make it likely that genetic manipulation and somatic gene therapy will become part of medical practice in this decade. In the case of the human cancers several possibilities arise for diagnosis, monitoring and treatment.
C, Kinnon, R J, Levinsky
openaire +2 more sources
INTRODUCTION RAPID advances in recombinant DNA technology make it likely that genetic manipulation and somatic gene therapy will become part of medical practice in this decade. In the case of the human cancers several possibilities arise for diagnosis, monitoring and treatment.
C, Kinnon, R J, Levinsky
openaire +2 more sources
Nature Medicine, 1995
As our knowledge of the basis of different cancers grows, so does the arsenal of specific weapons with which to fight the disease (pages 792–797).
Lowy, D.R., Willumsen, Berthe Marie
openaire +2 more sources
As our knowledge of the basis of different cancers grows, so does the arsenal of specific weapons with which to fight the disease (pages 792–797).
Lowy, D.R., Willumsen, Berthe Marie
openaire +2 more sources
Immunology Letters, 2000
Cytokines are crucial factors in the activation and development of immune response, including responses against tumor cells. Interleukin (IL)-2, a T-cell growth factor, has been largely used to activate T and NK cells in vivo and to maintain such an activation for therapeutic purposes. When given to patients, IL-2 was shown to cause clinical responses,
G, Parmiani +3 more
openaire +2 more sources
Cytokines are crucial factors in the activation and development of immune response, including responses against tumor cells. Interleukin (IL)-2, a T-cell growth factor, has been largely used to activate T and NK cells in vivo and to maintain such an activation for therapeutic purposes. When given to patients, IL-2 was shown to cause clinical responses,
G, Parmiani +3 more
openaire +2 more sources
New England Journal of Medicine, 1972
Cancer is occasionally a side-effect of therapy. Two articles in this week's Journal concern this area of tumor etiology. One describes a previously unrecognized risk, — cancer after intensive therapy in Hodgkin's disease,—and the other refutes an association — that tonsillectomy predisposes to Hodgkin's disease.
openaire +2 more sources
Cancer is occasionally a side-effect of therapy. Two articles in this week's Journal concern this area of tumor etiology. One describes a previously unrecognized risk, — cancer after intensive therapy in Hodgkin's disease,—and the other refutes an association — that tonsillectomy predisposes to Hodgkin's disease.
openaire +2 more sources
Postgraduate Medicine, 1979
With increased survival of increasing numbers of cancer patients as a result of therapy, the consequences, early and late, of the therapies must be realized. It is the treating physician's duty to preserve as much reproductive potential as possible for patients, consistent with adequate care. With radiotherapy this means shielding the gonads as much as
openaire +2 more sources
With increased survival of increasing numbers of cancer patients as a result of therapy, the consequences, early and late, of the therapies must be realized. It is the treating physician's duty to preserve as much reproductive potential as possible for patients, consistent with adequate care. With radiotherapy this means shielding the gonads as much as
openaire +2 more sources
Bisphosphonates in cancer therapy
Cancer Letters, 2007Bisphosphonates are the standard of care in the treatment of malignant bone diseases, because of their ability to inhibit osteoclast-mediated bone destruction. We review here preclinical evidence that bisphosphonates also exert direct antitumour effects and antiangiogenic properties.
Verena, Stresing +4 more
openaire +2 more sources
Urology, 1989
Cytokines, small biological response modifying proteins produced by hematopoietic and other cells, may one day play a significant role in the treatment of human cancer. This article presents an overview of the cytokines, including descriptions of their origins, mechanisms of action, and antitumor activities.
openaire +2 more sources
Cytokines, small biological response modifying proteins produced by hematopoietic and other cells, may one day play a significant role in the treatment of human cancer. This article presents an overview of the cytokines, including descriptions of their origins, mechanisms of action, and antitumor activities.
openaire +2 more sources
Antithrombotic therapy and cancer
Current Opinion in Hematology, 2004To assess the current evidence from recent clinical trials investigating antithrombotic agents for the prophylaxis and treatment of venous thromboembolism in cancer patients and for the effects of these agents on cancer progression.A growing body of evidence supports the preventive use of antithrombotic strategies in subgroups of cancer patients ...
DI NISIO M +4 more
openaire +4 more sources
Archives of Otolaryngology - Head and Neck Surgery, 1966
PROGRESS in the treatment of cancer of the larynx has been continuous, with several milestones, some detours, but in general, a progressive accumulation of concepts of both the clinical nature of the disease and of its management. It is, in fact, a paradox that there has been any significant progress when the underlying disease or conditions that ...
openaire +2 more sources
PROGRESS in the treatment of cancer of the larynx has been continuous, with several milestones, some detours, but in general, a progressive accumulation of concepts of both the clinical nature of the disease and of its management. It is, in fact, a paradox that there has been any significant progress when the underlying disease or conditions that ...
openaire +2 more sources